TY - JOUR AU - Langley, Ruth Elizabeth PY - 2018 TI - The direction of travel to better outcomes for patients with oesophago-gastric cancer JF - Journal of Thoracic Disease; Vol 10, No 3 (March 31, 2018): Journal of Thoracic Disease Y2 - 2018 KW - N2 - Globally, oesophago-gastric cancers account for 10% of cancer incidence and approximately 14% of cancer deaths, with a preponderance in males, and in low and middle-income countries (1). The traditional histological classifications, squamous versus adenocarcinoma, and intestinal versus diffuse, as well as the anatomical delineators (oesophageal, junctional and gastric), are being superseded by molecular-based classifications (2,3). The aim is to identify patients whose outcomes can be improved by the judicious use of standard chemotherapeutic agents and/ or novel targeted therapies. UR - https://jtd.amegroups.org/article/view/19773